Evidence map›Paper›PMID 28654704›Full record

ArticlePloS one2017

2,5-hexanedione downregulates nerve growth factor and induces neuron apoptosis in the spinal cord of rats via inhibition of the PI3K/Akt signaling pathway.

Zhemin Wang, Zewen Qiu, Chenxue Gao, Yijie Sun, Wei Dong, Yan Zhang, Ruolin Chen, Yuan Qi, Shuangyue Li, Yanjie Guo and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Zhemin WangDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Zewen QiuLaboratory Animal center, Dalian Medical University, Dalian, Liaoning, China.
Chenxue GaoDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Yijie SunDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Wei DongDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Yan ZhangDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Ruolin ChenDepartment of Sexually Transmitted Disease, Heping Center for Disease Control and Prevention of Tianjin, Tianjin, China.
Yuan QiDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Shuangyue LiDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.
Yanjie GuoDepartment of Biochemistry, Dalian Medical University, Dalian, Liaoning, China.
Yongjun PiaoDepartment of Dermatology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Sheng LiDepartment of Biochemistry, Dalian Medical University, Dalian, Liaoning, China.
Fengyuan PiaoDepartment of Occupational and Environmental Health, Dalian Medical University, Dalian, Liaoning, China.ORCID http://orcid.org/0000-0001-8582-3097
Dalian Medical University · CNTianjin Centers for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2,5-hexanedione (2,5-HD) is the main active metabolite of n-hexane and induces apoptosis in nerve tissue, however, the mechanism of which remains unclear. In the present study, neuropathic animal models were successfully constructed in rats by injecting 100, 200 and 400 mg/kg 2,5-HD intraperitoneally for 5 weeks. Rats exposed to 2,5-HD exhibited progressive gait abnormalities and slower motor neural response in a dose-dependent manner. TUNEL analysis and immunofluorescence dual labeling revealed that the spinal cord of the 2,5-HD treated rats underwent significantly more apoptosis in the cells of spinal cord than that of the control group. The neuron apoptosis index in spinal cord was 4.1%, 6.7%, 9.8% respectively in rats exposed to 100, 200 and 400 mg/kg 2,5-HD, compared with 1.1% in the control group (p < 0.05). Biochemical analysis showed that 2,5-HD exposure downregulated NGF expression in the spinal cord of the intoxicated rats; inhibited the phosphorylation of Akt and Bad, two key players in PI3K/Akt pathway downstream of NGF; increased the dimerization of Bad with Bcl-xL in the mitochondrial fraction, followed by the release of cytochrome c and activation of caspase-3 in the spinal cord of rats. In vitro study showed that the NGF expression decreased significantly in VSC4.1 cells dosed with 5.0, 10.0 mM 2,5-HD in comparison with the control group. It was also found that NGF supplement repressed the induced apoptosis, and increased p-Akt and p-Bad level in 2,5-HD treated VSC4.1 cells, which could be antagonized by PI3K kinase (the upstream member of Akt) inhibitor LY294002. Taken together, our experimental results indicate that 2,5-HD may induce apoptosis in the spinal cord of rats via downregulating NGF expression and subsequently repressing PI3K/Akt signaling pathway.

Indexed as

AnimalsApoptosisCaspase 3Down-RegulationHexanonesMaleNerve Growth FactorNeuronsPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleySignal TransductionSpinal Cord2,5-hexanedioneCaspase 3HexanonesNerve Growth FactorPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID28654704
PMCPMC5487034
OpenAlexW2727218717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.